Ownership history in Checkpoint Capital L.P. · 7 quarters on record
This page tracks every 13F SEC filing in which Checkpoint Capital L.P. reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 128,300 | -273,095 | -68.0% | 1.39% | $4.5M | $34.80 |
| 2025 Q4 | ADDED | 401,395 | +9,064 | +2.3% | 4.36% | $14.0M | $34.80 |
| 2025 Q3 | ADDED | 392,331 | +48,414 | +14.1% | 10.92% | $32.6M | $83.11 |
| 2025 Q2 | ADDED | 343,917 | +338,917 | +6778.3% | 11.76% | $25.2M | $73.40 |
| 2025 Q1 | REDUCED | 5,000 | -239,750 | -98.0% | 0.31% | $571K | $114.22 |
| 2024 Q2 | REDUCED | 244,750 | -29,026 | -10.6% | 4.79% | $8.0M | $32.49 |
| 2024 Q1 | INITIATED | 273,776 | — | — | 4.61% | $6.9M | — |
As of 2025 Q4 — sorted by position size